ICD-10-CM Diagnosis Code C79.5 - Secondary malignant neoplasm of bone and bone marrow (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- C00–D49
- C76-C80
- C79
- 2026 ICD-10-CM Code C79.5
Secondary malignant neoplasm of bone and bone marrow
ICD-10-CM Code:
C79.5
ICD-10 Code for:
Secondary malignant neoplasm of bone and bone marrow
Is Billable?
Not Valid for Submission
Code Navigator:
C79.5 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity from the list below for a diagnosis of secondary malignant neoplasm of bone and bone marrow. The code is not specific and is NOT valid for the year 2026 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic femur (any part) .
Non-specific codes like C79.5 require more digits to indicate the appropriate level of specificity. Consider using any of the following billable codes with a higher level of specificity when coding for secondary malignant neoplasm of bone and bone marrow:
Use C79.51 for Secondary malignant neoplasm of bone
Use C79.52 for Secondary malignant neoplasm of bone marrow
- Code Information
- Specific Coding
- Tabular List of Diseases and Injuries
- Table of Neoplasms
- Patient Education
- Other Codes Used Similar Conditions
- Code History
- Neoplasms
C00–D49
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Filter table of neoplasms:
| Neoplasm, neoplastic | Malignant Primary | Malignant Secondary | CaInSitu | Benign | Uncertain Behavior | Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »femur (any part) | C40.2 | C79.5 | D16.2 |
Bone Cancer
Cancer that starts in a bone is uncommon. Cancer that has spread to the bone from another part of the body is more common.
There are three types of bone cancer:
- Osteosarcoma - occurs most often between ages 10 and 19. It is more common in the knee and upper arm.
- Chondrosarcoma - starts in cartilage, usually after age 40
- Ewing's sarcoma - occurs most often in children and teens under 19. It is more common in boys than girls.
The most common symptom of bone cancer is pain. Other symptoms vary, depending on the location and size of the cancer. Surgery is often the main treatment for bone cancer. Other treatments may include amputation, chemotherapy, and radiation therapy. Because bone cancer can come back after treatment, regular follow-up visits are important.
NIH: National Cancer Institute
Bone Marrow Diseases
Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting.
With bone marrow disease, there are problems with the stem cells or how they develop:
- In leukemia, a cancer of the blood, the bone marrow makes abnormal white blood cells
- In aplastic anemia, the bone marrow doesn't make red blood cells
- In myeloproliferative disorders, the bone marrow makes too many white blood cells
- Other diseases, such as lymphoma, can spread into the bone marrow and affect the production of blood cells
Causes of bone marrow diseases include genetics and environmental factors. Tests for bone marrow diseases include blood and bone marrow tests. Treatments depend on the disorder and how severe it is. They might involve medicines, blood transfusions or a bone marrow transplant.
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
